XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)
批准号:
10308550
负责人:
Sanjoy K Bhattacharya
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-12-01 至 2023-11-30
关键词:
AcademiaAgeAnteriorAwardBasic ScienceBig Data MethodsBiotechnologyBudgetsCaringClinicClinicalClinical ResearchCollaborationsCreativenessDevelopmentDevicesDiagnosisDisciplineDiseaseDrug Delivery SystemsDrug KineticsEnvironmentEthnic groupEyeEye DevelopmentEye diseasesFeedbackFellowshipFloridaFosteringFoundationsFundingFutureGoalsGrantHealth ProfessionalIndividualIndustryInstitutionInternationalInterventionJournalsKnowledgeLeadershipLearningLogisticsMedicineMetabolismMindMinority WomenMissionNatural regenerationNatureOccupationsOralParticipantPeer ReviewPersonsPharmacologic SubstancePharmacologyPharmacy (field)Positioning AttributePosterior eyeball segment structurePrivate PracticePublicationsRegenerative MedicineRequest for ApplicationsResearchResearch PersonnelRestRetinaSafetyScheduleScientistSocietiesStretchingStudentsTechnologyTherapeuticTranslational ResearchTranslationsTravelUnderrepresented MinorityVisionVision researchWomancareereditorialethnic diversityinsightinterestlecturesmedical schoolsmeetingsmemberneuroprotectionnovelnovel therapeutic interventionnovel therapeuticsoptic nerve regenerationposterspre-clinicalregenerative approachretinal ganglion cell regenerationsight restorationsocialsymposiumunpublished worksweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The present application requests funds to support travel for young scientists to attend the XV Biennial Meeting
of the Association for Ocular Pharmacology and Therapeutics (AOPT) in Miami from March 4th-7th, 2021. This
is a conference that brings together scientists who are developing new ways to treat eye diseases. AOPT is a
global not-for-profit 501(c)3 organization for scientists and individuals from all disciplines related to ocular
pharmacology and its therapeutic applications to eye disease. AOPT has a diverse, multi-national membership
composed of preclinical and clinical scientists, students, and healthcare professionals. Members are from
academic institutions, pharma and biotech industries, device companies, clinics and private practice. To
achieve its mission, the society organizes biennial conferences and provides editorial leadership for the peer-
reviewed Journal of Ocular Pharmacology and Therapeutics. The mission of AOPT is threefold (from AOPT
website: www.aopt.org): (1) To serve as a global forum and network for the publication, dissemination and
exchange of information and knowledge on treatments of eye diseases, from basic and clinical ocular
pharmacology and therapeutics to related disciplines such as pharmacokinetics and dynamics, metabolism,
translational research, safety, drug delivery, and pharmaceutics; (2)To promote the advancement of research
and scientific progress in these fields; (3) To assist researchers and eye-care professionals in furthering their
understanding of the treatment of ocular disorders. In line with the AOPT mission, the specific Aims of the R13
application is: (I) To enhance the emerging careers of 20 young scientists (including women and
underrepresented minorities) in ocular therapeutics by providing travel awards; (II) To provide a forum for
dissemination of the most recent advances in the state of knowledge on novel therapeutic approaches to
ocular disorders and disease; (III) To create an environment that will facilitate the exchange of novel ideas
among basic and clinician scientists and generate the opportunity for vision scientists of all ethnic groups and
social backgrounds to meet and establish research collaborations. The theme of AOPT-2021 is “Restoring
vision through Regeneration” and a number of sessions are scheduled which are focused on regenerative
medicine related to anterior as well as posterior eye segments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impaired phospholipid metabolism in glaucoma
-
批准号:10396133
-
项目类别:
-
资助金额:$22.94万
-
财政年份:2021
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Impaired phospholipid metabolism in glaucoma
-
批准号:10356920
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2021
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Impaired phospholipid metabolism in glaucoma
-
批准号:10577808
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2021
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)
-
批准号:10515332
-
项目类别:
-
资助金额:$2.9万
-
财政年份:2020
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC Cohorts
-
批准号:9340195
-
项目类别:
-
资助金额:$67.54万
-
财政年份:2016
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA
-
批准号:7884885
-
项目类别:
-
资助金额:$19.14万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA
-
批准号:7141415
-
项目类别:
-
资助金额:$29.73万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Trabecular Meshwork Proteins in Glaucoma
-
批准号:8235226
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA
-
批准号:7659537
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Trabecular Meshwork Proteins in Glaucoma
-
批准号:8585850
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA
-
批准号:7879932
-
项目类别:
-
资助金额:$29.42万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Trabecular Meshwork Proteins in Glaucoma
-
批准号:8775224
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Trabecular Meshwork Proteins in Glaucoma
-
批准号:8383099
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA
-
批准号:7257027
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
TRABECULAR MESHWORK PROTEINS IN GLAUCOMA
-
批准号:7473855
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Trabecular Meshwork Proteins in Glaucoma
-
批准号:8533524
-
项目类别:
-
资助金额:$18.48万
-
财政年份:2006
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Proteomic Analyses of Human Trabecular Meshwork
-
批准号:7188305
-
项目类别:
-
资助金额:$8.19万
-
财政年份:2005
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Proteomic Analyses of Human Trabecular Meshwork
-
批准号:7110235
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2005
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Proteomic Analyses of Human Trabecular Meshwork
-
批准号:7269876
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2005
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
Proteomic Analyses of Human Trabecular Meshwork
-
批准号:6921076
-
项目类别:
-
资助金额:$7.11万
-
财政年份:2005
-
负责人:Sanjoy K Bhattacharya
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: